Literature DB >> 10225814

Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis.

G Hayem1, M De Bandt, E Palazzo, S Roux, B Combe, J F Eliaou, J Sany, M F Kahn, O Meyer.   

Abstract

OBJECTIVES: Stress proteins (HSPs) are highly conserved immunodominant antigens found in various species. The purpose of this study was to assess the prevalence and prognostic significance of antibodies to HSC 70 kDa and HSP 90 kDa in three groups of patients with longstanding rheumatoid arthritis (RA) defined based on the severity of articular erosions.
METHODS: 73 patients with longstanding (> 6 years) RA whose HLA-DR genotype was known were divided in three groups according to Larsen's score and compared with 47 recent onset (<1 year) RA patients and with control groups composed of patients with other inflammatory diseases (n=137) or of normal controls (n=48). IgGs and IgMs to HSC 70 kDa and HSP 90 kDa were determined using an ELISA with purified bovine HSC 70kDa or HSP 90 kDa.
RESULTS: Concentrations of IgGs and IgMs to HSC 70 were significantly increased in 41.1% and 42.5% of longstanding RA patients, respectively. Corresponding figures for IgGs and IgMs to HSP 90 were 39.7% and 56%. IgMs to HSC 70 and HSP 90 were less frequent in recent onset RA (19% and 13% respectively). Among the groups with other inflammatory diseases, only the MCTD group exhibited high frequencies of IgGs to HSC 70 (80%) and HSP 90 (85%). DRB1*0401 positive RA patients (n=23) were not more likely to have increased concentrations of antibodies to HSC 70 kDa or HSP 90 kDa than other RA patients (DR4 positive but DRB1*0401 negative, or DR1 positive, n=31; or negative for both DR4 and DR1, n=14). IgGs to HSP 90 kDa were significantly more frequent (p<0.05) in longstanding RA patients whose Larsen's score was 4 or more (57%) than in those whose Larsen's score was 2 or 3 (39.4%) or less than 2 (16%). No associations were found between Larsen's score and IgGs or IgMs to HSC 70 kDa or IgMs to HSP 90 kDa. A significant correlation was demonstrated between IgGs to HSP 90 kDa and two other serological markers for RA, rheumatoid factor, and anti-Sa antibody; there were no correlations with antikeratin antibody, antiperinuclear factor, or anti-RA 33.
CONCLUSION: IgGs to HSP 90 kDa are most common in longstanding RA patients with articular erosions, suggesting that they may be related to the articular prognosis in RA

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225814      PMCID: PMC1752878          DOI: 10.1136/ard.58.5.291

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus.

Authors:  S Minota; S Koyasu; I Yahara; J Winfield
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

3.  Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies.

Authors:  O Meyer; F Tauxe; D Fabregas; C Gabay; M Goycochea; T Haim; A Elias; M F Kahn
Journal:  Clin Exp Rheumatol       Date:  1993 Sep-Oct       Impact factor: 4.473

4.  Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.

Authors:  T T Möttönen
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

5.  Antibodies to the constitutive 73-kd heat shock protein: a new marker of mixed connective tissue disease?

Authors:  N Mairesse; M F Kahn; T Appelboom
Journal:  Am J Med       Date:  1993-12       Impact factor: 4.965

6.  Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis.

Authors:  G Tsoulfa; G A Rook; J D Van-Embden; D B Young; A Mehlert; D A Isenberg; F C Hay; P M Lydyard
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

7.  HLA-DR4 restricted lymphocyte proliferation to a Mycobacterium tuberculosis extract in rheumatoid arthritis and healthy subjects.

Authors:  A A Palacios-Boix; I Estrada-G; M J Colston; G S Panayi
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

8.  Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis.

Authors:  G Tsoulfa; G A Rook; G M Bahr; M A Sattar; K Behbehani; D B Young; A Mehlert; J D Van-Embden; F C Hay; D A Isenberg
Journal:  Scand J Immunol       Date:  1989-11       Impact factor: 3.487

9.  T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage.

Authors:  J Holoshitz; A Klajman; I Drucker; Z Lapidot; A Yaretzky; A Frenkel; W van Eden; I R Cohen
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

10.  Autoantibodies to the constitutive 73-kD member of the hsp70 family of heat shock proteins in systemic lupus erythematosus.

Authors:  S Minota; B Cameron; W J Welch; J B Winfield
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?

Authors:  Tangchun Wu; Robert M Tanguay
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 2.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

3.  Analysis of serum heat shock protein 70 (HSPA1A) concentrations for diagnosis and disease activity monitoring in patients with rheumatoid arthritis.

Authors:  Seyed Reza Najafizadeh; Zaniar Ghazizadeh; Arash Aghajani Nargesi; Masoud Mahdavi; Shabnam Abtahi; Hossein Mirmiranpour; Manouchehr Nakhjavani
Journal:  Cell Stress Chaperones       Date:  2015-03-06       Impact factor: 3.667

4.  Coexposure to mercury increases immunotoxicity of trichloroethylene.

Authors:  Kathleen M Gilbert; Benjamin Rowley; Horacio Gomez-Acevedo; Sarah J Blossom
Journal:  Toxicol Sci       Date:  2010-11-17       Impact factor: 4.849

5.  Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients.

Authors:  J Goral; S Shenoy; T Mohanakumar; J Clancy
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

6.  Heat shock protein and apoptosis in supraspinatus tendinopathy.

Authors:  Neal L Millar; Ai Q Wei; Timothy J Molloy; Fiona Bonar; George A C Murrell
Journal:  Clin Orthop Relat Res       Date:  2008-05-06       Impact factor: 4.176

Review 7.  The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal.

Authors:  Min-Nung Huang; Hua Yu; Kamal D Moudgil
Journal:  Semin Arthritis Rheum       Date:  2009-12-06       Impact factor: 5.532

8.  The immunosuppressive and protective ability of glucose-regulated protein 78 for improvement of alloimmunity in beta cell transplantation.

Authors:  M Wang; P Wang; Y Q Liu; J L Peng; X P Zhao; S Wu; F R He; X Wen; Y Li; G X Shen
Journal:  Clin Exp Immunol       Date:  2007-10-23       Impact factor: 4.330

9.  Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study.

Authors:  L Gossec; M Dougados; P Goupille; A Cantagrel; J Sibilia; O Meyer; J Sany; J-P Daurès; B Combe
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

10.  Genome-wide gene-based analysis of rheumatoid arthritis-associated interaction with PTPN22 and HLA-DRB1.

Authors:  Bo Qiao; Chien Hsun Huang; Lei Cong; Jun Xie; Shaw-Hwa Lo; Tian Zheng
Journal:  BMC Proc       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.